S&P 500   0.61 (-2.86%)
DOW   0.61 (-2.86%)
S&P 500   0.61 (-2.86%)
DOW   0.61 (-2.86%)
S&P 500   0.61 (-2.86%)
DOW   0.61 (-2.86%)
S&P 500   0.61 (-2.86%)
DOW   0.61 (-2.86%)
Log in

NASDAQ:AXSMAxsome Therapeutics News Headlines

$82.09
+2.67 (+3.36 %)
(As of 07/16/2020 08:57 AM ET)
Add
Compare
Today's Range
$78.59
Now: $82.09
$82.76
50-Day Range
$72.27
MA: $78.59
$85.79
52-Week Range
$13.64
Now: $82.09
$109.94
Volume395,200 shs
Average Volume613,026 shs
Market Capitalization$3.04 billion
P/E RatioN/A
Dividend YieldN/A
Beta3.13

Headlines

Axsome Therapeutics (NASDAQ AXSM) News Headlines

Source:
DateHeadline
HC Wainwright Reiterates Buy Rating for Axsome Therapeutics (NASDAQ:AXSM)HC Wainwright Reiterates Buy Rating for Axsome Therapeutics (NASDAQ:AXSM)
www.americanbankingnews.com - July 16 at 5:37 AM
FY2020 EPS Estimates for Axsome Therapeutics Inc Cut by Analyst (NASDAQ:AXSM)FY2020 EPS Estimates for Axsome Therapeutics Inc Cut by Analyst (NASDAQ:AXSM)
www.americanbankingnews.com - July 15 at 7:48 PM
Axsome Focuses on Filling NDAs for Two CNS Candidates in 2020Axsome Focuses on Filling NDAs for Two CNS Candidates in 2020
finance.yahoo.com - July 15 at 2:02 PM
HC Wainwright Reaffirms Buy Rating for Axsome Therapeutics (NASDAQ:AXSM)HC Wainwright Reaffirms Buy Rating for Axsome Therapeutics (NASDAQ:AXSM)
www.marketbeat.com - July 15 at 3:05 AM
Axsomes NDA for Depressive Disorder Drug on Track in Q420Axsome's NDA for Depressive Disorder Drug on Track in Q420
www.nasdaq.com - July 14 at 3:32 PM
Axsome's NDA for Depressive Disorder Drug on Track in Q420Axsome's NDA for Depressive Disorder Drug on Track in Q420
finance.yahoo.com - July 14 at 3:32 PM
Axsome Therapeutics Inc (NASDAQ:AXSM) Expected to Post Earnings of -$0.54 Per ShareAxsome Therapeutics Inc (NASDAQ:AXSM) Expected to Post Earnings of -$0.54 Per Share
www.americanbankingnews.com - July 14 at 10:24 AM
Axsome Therapeutics on track to file AXS-05 application in Q4Axsome Therapeutics on track to file AXS-05 application in Q4
seekingalpha.com - July 13 at 2:24 PM
Axsome Therapeutics Completes Successful FDA Pre-NDA Meeting for AXS-05 for the Treatment of Major Depressive DisorderAxsome Therapeutics Completes Successful FDA Pre-NDA Meeting for AXS-05 for the Treatment of Major Depressive Disorder
finance.yahoo.com - July 13 at 9:23 AM
Heres Why Axsome Therapeutics Fell 20.4% in the First Half of 2020Here's Why Axsome Therapeutics Fell 20.4% in the First Half of 2020
www.fool.com - July 8 at 2:52 PM
Here's Why Axsome Therapeutics Fell 20.4% in the First Half of 2020Here's Why Axsome Therapeutics Fell 20.4% in the First Half of 2020
finance.yahoo.com - July 8 at 2:52 PM
3 “Perfect 10” Healthcare Stocks That Have Plenty of Growth on Tap3 “Perfect 10” Healthcare Stocks That Have Plenty of Growth on Tap
finance.yahoo.com - July 7 at 1:40 PM
What Kind Of Investors Own Most Of Axsome Therapeutics, Inc. (NASDAQ:AXSM)?What Kind Of Investors Own Most Of Axsome Therapeutics, Inc. (NASDAQ:AXSM)?
finance.yahoo.com - July 3 at 5:15 PM
Axsome Therapeutics Inc (NASDAQ:AXSM) Given Average Recommendation of "Buy" by BrokeragesAxsome Therapeutics Inc (NASDAQ:AXSM) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - July 3 at 10:31 AM
Nick Pizzie Acquires 777 Shares of Axsome Therapeutics Inc (NASDAQ:AXSM) StockNick Pizzie Acquires 777 Shares of Axsome Therapeutics Inc (NASDAQ:AXSM) Stock
www.americanbankingnews.com - June 30 at 8:32 AM
Axsome Therapeutics Inc (NASDAQ:AXSM) Director Acquires $51,025.00 in StockAxsome Therapeutics Inc (NASDAQ:AXSM) Director Acquires $51,025.00 in Stock
www.marketbeat.com - June 30 at 8:32 AM
Axsome Therapeutics (NASDAQ:AXSM) Stock Rating Reaffirmed by HC WainwrightAxsome Therapeutics (NASDAQ:AXSM) Stock Rating Reaffirmed by HC Wainwright
www.americanbankingnews.com - June 30 at 6:33 AM
Axsomes AXS-05 Gets Breakthrough Therapy Tag for AD AgitationAxsome's AXS-05 Gets Breakthrough Therapy Tag for AD Agitation
finance.yahoo.com - June 29 at 9:53 PM
Why Axsome Therapeutics Stock Is Sinking TodayWhy Axsome Therapeutics Stock Is Sinking Today
www.fool.com - June 29 at 4:53 PM
Stock Alert: Axsome Therapeutics Climbs 9% As Its AXS-05 Gets Breakthrough Therapy DesignationStock Alert: Axsome Therapeutics Climbs 9% As Its AXS-05 Gets Breakthrough Therapy Designation
www.nasdaq.com - June 26 at 1:07 PM
Why Axsome Therapeutics Stock Is Jumping TodayWhy Axsome Therapeutics Stock Is Jumping Today
www.fool.com - June 26 at 1:07 PM
Axsome nabs accelerated review in U.S. for Alzheimers candidate AXS-05Axsome nabs accelerated review in U.S. for Alzheimer's candidate AXS-05
seekingalpha.com - June 26 at 8:07 AM
Axsome Therapeutics Receives FDA Breakthrough Therapy Designation for AXS-05 for the Treatment of Alzheimer’s Disease AgitationAxsome Therapeutics Receives FDA Breakthrough Therapy Designation for AXS-05 for the Treatment of Alzheimer’s Disease Agitation
finance.yahoo.com - June 26 at 8:07 AM
-$0.54 EPS Expected for Axsome Therapeutics Inc (NASDAQ:AXSM) This Quarter-$0.54 EPS Expected for Axsome Therapeutics Inc (NASDAQ:AXSM) This Quarter
www.americanbankingnews.com - June 22 at 3:17 AM
Axsome Looks Extremely Undervalued After Recent Share Price DeclineAxsome Looks Extremely Undervalued After Recent Share Price Decline
seekingalpha.com - June 21 at 11:02 PM
Axsome Therapeutics, Inc. (AXSM): Are Hedge Funds Done Buying?Axsome Therapeutics, Inc. (AXSM): Are Hedge Funds Done Buying?
finance.yahoo.com - June 15 at 5:23 PM
Axsome Therapeutics Becomes Oversold (AXSM)Axsome Therapeutics Becomes Oversold (AXSM)
www.nasdaq.com - June 12 at 3:08 PM
Why Is Axsome (AXSM) Down 15.7% Since Last Earnings Report?Why Is Axsome (AXSM) Down 15.7% Since Last Earnings Report?
finance.yahoo.com - June 7 at 2:57 PM
Axsome Therapeutics Presents Data from GEMINI Phase 3 Trial of AXS-05 in Major Depressive Disorder at the 2020 American Society for Clinical Psychopharmacology Annual MeetingAxsome Therapeutics Presents Data from GEMINI Phase 3 Trial of AXS-05 in Major Depressive Disorder at the 2020 American Society for Clinical Psychopharmacology Annual Meeting
finance.yahoo.com - May 29 at 10:03 AM
Is Axsome Therapeutics a Buy?Is Axsome Therapeutics a Buy?
finance.yahoo.com - May 26 at 1:27 PM
Axsome Therapeutics to Host 2020 Annual Meeting of Stockholders VirtuallyAxsome Therapeutics to Host 2020 Annual Meeting of Stockholders Virtually
finance.yahoo.com - May 26 at 8:26 AM
Axsome Therapeutics: Sliding Share Price And FDA Approvals Highlight GainsAxsome Therapeutics: Sliding Share Price And FDA Approvals Highlight Gains
seekingalpha.com - May 22 at 7:31 AM
Could Opioids Treat Depression? This Biotech Plans to Find OutCould Opioids Treat Depression? This Biotech Plans to Find Out
www.fool.com - May 19 at 7:52 AM
Whats Behind Axsome Therapeutics Miracle Pipeline?What's Behind Axsome Therapeutics' Miracle Pipeline?
www.fool.com - May 19 at 7:52 AM
Axsome's (AXSM) Earnings Miss in Q1, Pipeline ProgressesAxsome's (AXSM) Earnings Miss in Q1, Pipeline Progresses
finance.yahoo.com - May 11 at 5:54 PM
Axsome Therapeutics, Inc. (AXSM) Q1 2020 Earnings Call TranscriptAxsome Therapeutics, Inc. (AXSM) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 9 at 4:19 PM
Why Jazz Pharmaceuticals' Symphony of Growth Is About to EndWhy Jazz Pharmaceuticals' Symphony of Growth Is About to End
finance.yahoo.com - May 9 at 8:53 AM
Edited Transcript of AXSM earnings conference call or presentation 8-May-20 12:00pm GMTEdited Transcript of AXSM earnings conference call or presentation 8-May-20 12:00pm GMT
finance.yahoo.com - May 9 at 3:52 AM
Axsome Therapeutics +2% on Q1 resultsAxsome Therapeutics +2% on Q1 results
seekingalpha.com - May 8 at 5:51 PM
Axsome Therapeutics, Inc. (AXSM) CEO Herriot Tabuteau on Q1 2020 Results - Earnings Call TranscriptAxsome Therapeutics, Inc. (AXSM) CEO Herriot Tabuteau on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 8 at 5:51 PM
Axsome Therapeutics Reports First Quarter 2020 Financial Results and Provides Business UpdateAxsome Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - May 8 at 5:51 PM
Heres Why Axsome Therapeutics Rocketed 61.5% Higher in AprilHere's Why Axsome Therapeutics Rocketed 61.5% Higher in April
www.fool.com - May 3 at 4:19 PM
Here's Why Axsome Therapeutics Rocketed 61.5% Higher in AprilHere's Why Axsome Therapeutics Rocketed 61.5% Higher in April
finance.yahoo.com - May 3 at 4:19 PM
There May Be a New First-Line Treatment for DepressionThere May Be a New First-Line Treatment for Depression
www.fool.com - April 30 at 5:37 PM
Axsome Shares Jump 25% on Alzheimers Study ResultsAxsome Shares Jump 25% on Alzheimer's Study Results
finance.yahoo.com - April 28 at 1:14 PM
AMRN, EPR among top gainersAMRN, EPR among top gainers
seekingalpha.com - April 27 at 5:12 PM
Axsome Therapeutics Drug Trial Shows Eased Agitation in Alzheimers PatientsAxsome Therapeutics Drug Trial Shows Eased Agitation in Alzheimer's Patients
www.thestreet.com - April 27 at 5:12 PM
Thinking about trading stocks or options in Apple, Axsome Therapeutics, Walt Disney, Royal Caribbean Cruises, or Trade Desk?Thinking about trading stocks or options in Apple, Axsome Therapeutics, Walt Disney, Royal Caribbean Cruises, or Trade Desk?
www.prnewswire.com - April 27 at 12:11 PM
Why This Alzheimers Study Could Be HugeWhy This Alzheimer's Study Could Be Huge
247wallst.com - April 27 at 12:11 PM
Drug Combination Helps Alzheimers Disease Patients in Pivotal StudyDrug Combination Helps Alzheimer's Disease Patients in Pivotal Study
www.fool.com - April 27 at 12:11 PM
This page was last updated on 7/16/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.